Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.77 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.77 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.77 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.77 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.77 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.77 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.77 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20209368 | 0.90 | CYP1A2 (0.84) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20208667 | 0.89 | KCNH2 (0.78) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20208648 | 0.88 | CYP1A2 (0.77) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20209110 | 0.88 | KCNH2 (0.77) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20209396 | 0.88 | KCNH2 (0.98) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20208591 | 0.87 | CYP1A2 (0.65) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20208771 | 0.86 | CYP1A2 (0.73) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20209070 | 0.86 | CYP1A2 (0.73) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20208569 | 0.85 | CYP1A2 (0.72) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 | |
| SCHEMBL20209120 | 0.85 | CYP1A2 (0.72) | CYP1A2CYP3A4CYP2C8CYP2D6CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3546454-B1 | BENZOHETEROCYCLYL ALKYLAMINE COMPOUND AND USE THEREOF | UNIV EAST CHINA SCIENCE & TECH (CN) | 2023-09-27 | — | — | EP | disclosed |
| US-10829464-B2 | Benzoheterocyclic alkylamine compounds and use thereof | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2020-11-10 | — | — | US | disclosed |
| US-20190315703-A1 | BENZOHETEROCYCLIC ALKYLAMINE COMPOUNDS AND USE THEREOF | EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2019-10-17 | — | — | US | disclosed |
| EP-3546454-A1 | BENZOHETEROCYCLYL ALKYLAMINE COMPOUND AND USE THEREOF | East China University of Science and Technology (CN) | 2019-10-02 | — | — | EP | disclosed |
| WO-2018095287-A1 | BENZOHETEROCYCLYL ALKYLAMINE COMPOUND AND USE THEREOF | 华东理工大学 | 2018-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10829464-B2 | Benzoheterocyclic alkylamine compounds and use thereof | AADAC, AAAS, NISCH | CYP1A2 1004/4885CYP3A4 1833/4885CYP2C8 2001/4885 |
| US-20190315703-A1 | BENZOHETEROCYCLIC ALKYLAMINE COMPOUNDS AND USE THEREOF | AADAC, AAAS, NISCH | CYP1A2 1004/4885CYP3A4 1833/4885CYP2C8 2001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.